person

Teemu M.

Country
Finland
Department
Urologian poliklinikka

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
155
Sites with multiple studies

Has run more than one trial at 155 of 334 partner sites.

Specializations

Advanced Prostate Cancer Management

This investigator specializes in treating metastatic castration-sensitive prostate cancer (mCSPC) and metastatic castration-resistant prostate cancer (mCRPC), with particular focus on novel therapeutic approaches using hormonal agents and targeted therapies.

  • Hormone Therapy Optimization
  • Novel Therapeutic Combinations
  • Treatment Resistance Management

Their research encompasses innovative treatment strategies for patients with advanced stages of prostate cancer.

Biochemical Recurrence

The investigator focuses on treating biochemically recurrent prostate cancer, particularly exploring the efficacy of combination treatments involving androgen deprivation therapy (ADT) and new therapeutic agents.

  • PSA Level Management
  • Early Intervention Strategies
  • Disease Progression Prevention

Their work includes monitoring and managing prostate cancer recurrence through advanced diagnostic and therapeutic approaches.

Supportive Care in Prostate Cancer

The investigator studies interventions to improve quality of life during prostate cancer treatment, with particular emphasis on managing treatment-related adverse effects and sexual dysfunction in patients undergoing therapy.

  • Side Effect Management
  • Quality of Life Enhancement
  • Hormone Therapy Optimization

Their research includes innovative approaches to mitigating treatment-related complications while maintaining therapeutic efficacy.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.